Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Aargo, accelerate, accredited, advisor, Amber, AMD, AMEX, appointed, Article, assist, assisted, Atari, ATC, ATI, auditor, automation, automotive, Award, Band, Berkeley, Cambridge, carefully, carryforward, Centennial, Center, CFO, Chartered, CREAF, Creative, David, declaration, declared, decreased, Dynamount, Electric, engine, entitled, event, experimental, extent, external, flat, foreign, Forum, full, fully, game, GEO, global, guidance, Head, home, Hundred, IEEE, Illuminati, InBay, incentive, initial, IPO, law, leading, leveraging, marginal, Medal, member, mentor, Micro, Microchip, microprocessor, modified, modifying, multimedia, NASD, NASDAQ, network, newly, Notwithstanding, offering, offshore, open, Optix, orphan, panel, PAUL, PC, PCAOB, Peekaboo, Pioneer, pioneered, prescribe, programmable, provisional, RCA, reduced, reduction, repatriated, repealing, respond, return, review, reviewed, reviewing, revoked, russo, Sage, SAGI, Sarnoff, science, Secretary, selected, semiconductor, served, serving, set, significantly, Silicon, simon, snapdna, ST, statute, subscription, TCJA, team, tech, technology, teslonix, Thrive, top, Trinity, Trump, TV, UC, uncertain, understanding, USA, utilizable, Valley, vehicle, video, westbrook, WOO
Removed:
achieve, acquire, Administration, anticipate, application, approve, assessing, autoimmune, biopharmaceutical, Canadian, cancer, clearance, clinical, commenced, commencement, commercial, competition, Department, designing, developed, expand, finally, forming, incur, innovative, introduced, level, marketplace, maximize, meet, merger, minimally, planned, platform, preclinical, product, projected, proliferate, receiving, refer, regulate, resulting, saleable, subsidiary, successfully, suffered, supporting, testing, toxic, unutilized, utility
Filing tables
Filing exhibits
- 10-K Annual report
- 31.1 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 31.2 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 32.1 Certificate Pursuant to Section 18 U.s.c. Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 32.2 Certificate Pursuant to Section 18 U.s.c. Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
KBPH similar filings
Filing view
External links
EXHIBIT 32.1
8CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 905 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Paul Russo, Chief Executive Officer of Kyto Technology and Life Science, Inc., a Florida corporation (the "Company"), do hereby certify, to the best of my knowledge, that:
(1) | The Company's Annual Report on Form 10-K for the period ended March 31, 2018, as filed with the Securities Exchange Commission on the date hereof (the "Report") fully complies, in all material respects, with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein. |
Date: June 28, 2018 | By: | /s/ Paul Russo | |
Paul Russo | |||
Chief Executive Officer | |||